Combination of tumor-associated surface protein antigens and tumorassociated sugars in the treatment and diagnosis of cancer

Details for Australian Patent Application No. 2010212349 (hide)

Owner Igeneon Krebs-Immuntherapie Forschungs-und Entwicklungs-AG

Inventors Loibner, Hans; Himmler, Gottfried

Agent Davies Collison Cave

Parent 2003266278

Filing date 13 August 2010

Event Publications

2 September 2010 Complete Application Filed

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212350-Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease

2010212348-Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders